CAS Medical Systems (CAS Medical Systems) Net-Net Working Capital : $-0.71 (As of Dec. 2018)

View and export this data going back to 1995. Start your Free Trial

What is CAS Medical Systems Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

CAS Medical Systems's Net-Net Working Capital for the quarter that ended in Dec. 2018 was $-0.71.

The industry rank for CAS Medical Systems's Net-Net Working Capital or its related term are showing as below:

CASM's Price-to-Net-Net-Working-Capital is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 6.44
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

CAS Medical Systems Net-Net Working Capital Historical Data

The historical data trend for CAS Medical Systems's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CAS Medical Systems Net-Net Working Capital Chart

CAS Medical Systems Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Net-Net Working Capital

Get a 7-Day Free Trial

-0.90

-0.53

-0.60

-0.56

-0.71

CAS Medical Systems Quarterly Data
	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18
Net-Net Working Capital	Get a 7-Day Free Trial															-0.56	-0.59	-0.64	-0.68	-0.71

Competitive Comparison of CAS Medical Systems's Net-Net Working Capital

For the Medical Instruments & Supplies subindustry, CAS Medical Systems's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CAS Medical Systems's Price-to-Net-Net-Working-Capital Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CAS Medical Systems's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where CAS Medical Systems's Price-to-Net-Net-Working-Capital falls into.

CAS Medical Systems Net-Net Working Capital Calculation

CAS Medical Systems's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2018 is calculated as

	Net-Net Working Capital		(A: Dec. 2018 )
=	(Cash, Cash Equivalents, Marketable Securities	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(3.272	+	0.75 * 3.183	+	0.5 * 1.012	-	13.113
-	13.938	-	0)	/	29.2552
=	-0.71

CAS Medical Systems's Net-Net Working Capital (NNWC) per share for the quarter that ended in Dec. 2018 is calculated as

	Net-Net Working Capital		(Q: Dec. 2018 )
=	(Cash, Cash Equivalents, Marketable Securities	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(3.272	+	0.75 * 3.183	+	0.5 * 1.012	-	13.113
-	13.938	-	0)	/	29.2552
=	-0.71

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.

CAS Medical Systems (NAS:CASM) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.

CAS Medical Systems Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of CAS Medical Systems's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

CAS Medical Systems (CAS Medical Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CAS Medical Systems Inc (NAS:CASM) » Definitions » Net-Net Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

44 East Industrial Road, Branford, CT, USA, 06405

Website

http://www.casmed.com

CAS Medical Systems Inc is a medical technology company that develops, manufactures, and markets non-invasive patient monitoring products. The company's products are the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. .

Executives

Alan Milinazzo	director	C/O ORTHOFIX INC, 10115 KINCEY AVENUE STE 250, HUNTERSVILLE NC 28078
Thomas M Patton	director, officer: President and CEO	C/O OSTEOTCH INC., 51 JAMES WAY, EATONTOWN NJ 07724
Kenneth R Weisshaar	director	875 PARK AVE APT 2D, NEW YORK NY 10021
James E Thomas	director, 10 percent owner	WOODS END ROAD, NEW CANAAN CT 06840
Thomas, Mcnerney & Partners Ii L.p.	10 percent owner	45 SOUTH 7TH STREET, SUITE 3060, Minneapolis MN 55402
Tmp Associates Ii Lp	10 percent owner	45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Tmp Nominee Ii, Llc	10 percent owner	45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Thomas, Mcnerney & Partners Ii, Llc	10 percent owner	45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Acuta Capital Fund, Lp	10 percent owner	1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002
James E Flynn	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Management Company, L.p. (series C)	10 percent owner, other: Possible Member of 10% Group	345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Mgmt L.p.	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations Fund, L.p.	10 percent owner, other: Possible Member of 10% Group	780 3RD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations International Master Fund, L.p.	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Lawrence Burstein	director	C/O UNITY VENTURE CAPITAL ASSOCIATES LTD, 245 FIFTH AVENUE, SUITE 1500, NEW YORK NY 10016